9:30am | Workshop A
Exploring Cutting-Edge Novel Formats of Bispecific Antibodies for Next-Generation Therapeutic Applications
Synopsis
- Exploring the landscape of novel bispecific drugs including bispecific antibody-drug conjugates, CAR-T therapies and beyond
- Leveraging advanced protein engineering techniques to design novel bispecific antibody constructs
- Case studies highlighting successful applications of novel bispecific antibody formats across various disease indications
- Optimizing novel antibody formats for enhanced target specificity, affinity, and stability
- Addressing translational challenges and regulator considerations in advancing novel bispecific antibody formats into clinical trials
- Exploring emerging trends and technological advancements shaping the future of bispecific antibody therapeutics
- Gain insights into the design, development, and clinical translation of next-generation bispecific antibodies
9:30 | Workshop B
Maximizing Bispecific Antibody Efficacy in Solid Tumors & Overcoming the Tumor Microenvironment
Synopsis
- Leveraging innovative research to identify promising targets within the tumor microenvironment for bispecific antibody drugs
- Optimizing bispecific antibody design and functionality for enhanced tumor penetration
- Engineering strategies to enhance bispecific antibody penetration into the solid tumor microenvironment
- Tailoring antibody formats and binding affinities for optimal target engagement and therapeutic effect
- Evaluating preclinical models and predictive tools for assessing bispecific antibody penetration and activity in solid tumors
- Addressing hurdles in translating preclinical bispecific success to clinical efficacy in solid tumor therapy
- Discover innovative strategies to optimize antibody design, overcome translational challenges, and propel the field towards effective clinical solutions for combating solid tumor progression
12:30 | Lunch Break
1:30pm | Workshop C
Harnessing the Potential of Multispecific Drugs & Combinations for Enhanced Therapeutic Outcomes
Synopsis
- Delving into the diverse landscape of multispecific drugs and their unique mechanisms of action
- Optimizing multispecific drug design for areas of unmet need like solid tumors
- Evaluating the clinical feasibility and therapeutic potential of novel combination approaches in diverse disease contexts
- Addressing key translational hurdles in developing multispecific drug combinations for clinical use
- Exploring emerging technology advancements driving the evolution of multispecific drugs and their use as combination therapies
- Join this workshop to gain valuable insights into the landscape of multispecific drugs and combination approaches to unlock improved and synergistic therapeutic outcomes
1:30pm | Workshop D
Streamlining the Discovery of Next-Generation Bispecific Antibodies
Synopsis
- Uncover the evolving landscape of bispecific antibody discovery platforms and cutting-edge technologies
- Highlighting applications of novel discovery platforms in generating next-generation bispecific antibodies
- Exploring advanced protein engineering techniques for the design and optimization of bispecific antibody scaffolds against novel targets
- Enhancing the integration of high-throughput screening, structural biology, and functional assays
- Overcoming challenges in scalability, manufacturability, and immunogenicity assessment during lead selection
- Join this workshop to gain deeper insights into the latest advancements in bispecific antibody development platforms to accelerate and de-risk your own in-house bispecific discovery